I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| platelet | 10 studies | 49% ± 19% | |
| megakaryocyte | 4 studies | 37% ± 13% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| platelet | 10 studies | 49% ± 19% | |
| megakaryocyte | 4 studies | 37% ± 13% |
Insufficient scRNA-seq data for expression of ACRBP at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| thymus | 100% | 580.55 | 653 / 653 | 100% | 10.06 | 602 / 605 |
| lung | 99% | 380.81 | 575 / 578 | 91% | 3.40 | 1053 / 1155 |
| prostate | 95% | 247.68 | 233 / 245 | 94% | 2.47 | 474 / 502 |
| pancreas | 95% | 120.55 | 310 / 328 | 95% | 3.61 | 169 / 178 |
| kidney | 90% | 118.63 | 80 / 89 | 91% | 6.18 | 816 / 901 |
| stomach | 89% | 119.92 | 321 / 359 | 91% | 4.03 | 259 / 286 |
| intestine | 88% | 152.56 | 851 / 966 | 88% | 3.33 | 465 / 527 |
| breast | 85% | 116.39 | 389 / 459 | 91% | 2.75 | 1021 / 1118 |
| bladder | 76% | 98.81 | 16 / 21 | 84% | 3.15 | 421 / 504 |
| uterus | 82% | 89.73 | 139 / 170 | 77% | 2.37 | 353 / 459 |
| ovary | 58% | 61.71 | 105 / 180 | 98% | 5.75 | 421 / 430 |
| esophagus | 64% | 61.60 | 925 / 1445 | 83% | 3.47 | 151 / 183 |
| skin | 67% | 68.11 | 1218 / 1809 | 74% | 2.13 | 347 / 472 |
| brain | 45% | 85.10 | 1198 / 2642 | 91% | 2.53 | 640 / 705 |
| liver | 78% | 97.27 | 177 / 226 | 56% | 1.48 | 229 / 406 |
| adrenal gland | 71% | 66.51 | 182 / 258 | 31% | 0.51 | 72 / 230 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 6.59 | 29 / 29 |
| spleen | 100% | 1095.35 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 1.75 | 1 / 1 |
| peripheral blood | 98% | 778.43 | 914 / 929 | 0% | 0 | 0 / 0 |
| adipose | 90% | 124.13 | 1085 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 75% | 1.62 | 60 / 80 |
| tonsil | 0% | 0 | 0 / 0 | 64% | 1.37 | 29 / 45 |
| blood vessel | 50% | 58.45 | 667 / 1335 | 0% | 0 | 0 / 0 |
| heart | 32% | 26.00 | 278 / 861 | 0% | 0 | 0 / 0 |
| muscle | 9% | 10.91 | 73 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0009566 | Biological process | fertilization |
| GO_0001675 | Biological process | acrosome assembly |
| GO_0008150 | Biological process | biological_process |
| GO_0007286 | Biological process | spermatid development |
| GO_0002080 | Cellular component | acrosomal membrane |
| GO_0001669 | Cellular component | acrosomal vesicle |
| GO_0005576 | Cellular component | extracellular region |
| GO_0005634 | Cellular component | nucleus |
| GO_0003674 | Molecular function | molecular_function |
| Gene name | ACRBP |
| Protein name | Acrosin-binding protein (Acrosin-binding protein, 60 kDa form) (Cancer/testis antigen 23) (CT23) (Cancer/testis antigen OY-TES-1) (Proacrosin-binding protein sp32) [Cleaved into: Acrosin-binding protein, mature form (Acrosin-binding protein, 32 kDa form, mature form)] Acrosin-binding protein (Acrosin-binding protein, 60 kDa form) (Proacrosin-binding protein sp32) |
| Synonyms | hCG_2002250 |
| Description | FUNCTION: [Acrosin-binding protein, mature form]: Acrosomal protein that maintains proacrosin (pro-ACR) as an enzymatically inactive zymogen in the acrosome. Involved also in the acrosome formation. . |
| Accessions | A0A140VJD6 Q8NEB7 ENST00000414226.6 F5H5S8 ENST00000546114.1 F5H3P4 ENST00000535884.5 ENST00000229243.7 F5H2C2 ENST00000536350.5 E7EP66 |
